Improving the Oral Bioavailability of an Anti-Glioma Prodrug CAT3 Using Novel Solid Lipid Nanoparticles Containing Oleic Acid-CAT3 Conjugates

Hierarchically targetable polysaccharide-coated solid lipid nanoparticles as an oral chemo/thermotherapy delivery system for local treatment of colon cancer

(2019) Ming-Yin Shen et al.   BIOMATERIALS

CAT3, a prodrug of 13a(S)-3-hydroxyl-6,7-dimethoxyphenanthro[9,10-b]-indolizidine, circumvents temozolomide-resistant glioblastoma via the Hedgehog signaling pathway, independently of O6-methylguanine DNA methyltransferase expression

(2018) Ming Ji et al.   OncoTargets and Therapy

Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation

(2018) Narendar Dudhipala et al.   Artificial Cells Nanomedicine and Biotechnology

Recent advances of polysaccharide-based nanoparticles for oral insulin delivery

(2018) Qiaobin Hu et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

A novel and practical synthesis of CAT3: a phenanthroindolizidine alkaloid with potential in treating glioblastoma

(2018) Ru-Bing Wang et al.   RSC Advances

Solid lipid nanoparticles and nanostructured lipid carriers: A review emphasizing on particle structure and drug release

(2018) Aldemar Gordillo-Galeano et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Skin permeation, biocompatibility and antitumor effect of chloroaluminum phthalocyanine associated to oleic acid in lipid nanoparticles

(2018) Ellen Denise P. Almeida et al.   Photodiagnosis and Photodynamic Therapy

Lipid nanovehicles with adjustable surface properties for overcoming multiple barriers simultaneously in oral administration

(2017) Lei Wu et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

CAT3, a novel agent for medulloblastoma and glioblastoma treatment, inhibits tumor growth by disrupting the Hedgehog signaling pathway

(2016) Ju Chen et al.   CANCER LETTERS

Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles

(2016) Gu Lingling et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Targeting autophagy to sensitive glioma to temozolomide treatment

(2016) Yuanliang Yan et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The histone demethylase KDM5A is a key factor for the resistance to temozolomide in glioblastoma

(2015) Barbara Banelli et al.   CELL CYCLE

Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: in vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior

(2015) Mubashar Rehman et al.   International Journal of Nanomedicine

The novel anti-neuroblastoma agent PF403, inhibits proliferation and invasion in vitro and in brain xenografts

(2015) CHAO LI et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach

(2015) Vivek Makwana et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Central Nervous System Cancers, Version 1.2015

(2015) Louis Burt Nabors et al.   Journal of the National Comprehensive Cancer Network

Glioblastoma multiforme: Pathogenesis and treatment

(2015) Constantinos Alifieris et al.   PHARMACOLOGY & THERAPEUTICS

Formulation, characterization and cytotoxicity studies of alendronate sodium-loaded solid lipid nanoparticles

(2014) Jafar Ezzati Nazhad Dolatabadi et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation

(2014) Narendar Dudhipala et al.   DRUG DELIVERY

Mannosylated solid lipid nanoparticles for lung-targeted delivery of Paclitaxel

(2014) Piyush Kumar Sahu et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals

(2014) Mona H Aburahma et al.   Expert Opinion on Drug Delivery

Mechanism Study of Cellular Uptake and Tight Junction Opening Mediated by Goblet Cell-Specific Trimethyl Chitosan Nanoparticles

(2014) Jian Zhang et al.   MOLECULAR PHARMACEUTICS

Transport Pathways of Solid Lipid Nanoparticles Across Madin–Darby Canine Kidney Epithelial Cell Monolayer

(2014) Gui-Hong Chai et al.   MOLECULAR PHARMACEUTICS

Evaluation of the DDSolver Software Applications

(2014) Jieyu Zuo et al.   Biomed Research International

Physical characterization andin vitroskin permeation of solid lipid nanoparticles for transdermal delivery of quercetin

(2014) S. B. Han et al.   INTERNATIONAL JOURNAL OF COSMETIC SCIENCE

Recent expansions in an emergent novel drug delivery technology: Emulgel

(2013) Ajazuddin et al.   JOURNAL OF CONTROLLED RELEASE

Improved Transport and Absorption through Gastrointestinal Tract by PEGylated Solid Lipid Nanoparticles

(2013) Hong Yuan et al.   MOLECULAR PHARMACEUTICS

Integrated rapid resolution liquid chromatography–tandem mass spectrometric approach for screening and identification of metabolites of the potential anticancer agent 3,6,7-trimethoxyphenanthroindolizidine in rat urine

(2012) Yaping Tian et al.   ANALYTICA CHIMICA ACTA

Development, characterization and in vivo assessment of effective lipidic nanoparticles for dermal delivery of fluconazole against cutaneous candidiasis

(2012) Madhu Gupta et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): Development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?

(2012) Surajit Das et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Synthesis, Biological Evaluation and Mechanism Studies of Deoxytylophorinine and Its Derivatives as Potential Anticancer Agents

(2012) Haining Lv et al.   PLoS One

Stereospecific Synthesis and Biological Evaluation of Monodesmethyl Metabolites of (+)-13a-(S)-Deoxytylophorinine as Potential Antitumor Agents

(2012) Shishan Yu et al.   SYNTHESIS-STUTTGART

Interaction Studies of an Anticancer Alkaloid, (+)-(13aS)-Deoxytylophorinine, with Calf Thymus DNA and Four Repeated Double-Helical DNAs

(2011) Zhenjia Liu et al.   CHEMOTHERAPY

DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles

(2010) Yong Zhang et al.   AAPS Journal

Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery

(2010) Surajit Das et al.   AAPS PHARMSCITECH

Formulation and targeting efficiency of cisplatin engineered solid lipid nanoparticles

(2009) RC Doijad et al.   INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES

The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol

(2009) K. Teskač et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

The performance of docetaxel-loaded solid lipid nanoparticles targeted to hepatocellular carcinoma

(2008) Zhenghong Xu et al.   BIOMATERIALS

Bioavailability of nanoparticles in nutrient and nutraceutical delivery

(2008) Edgar Acosta   CURRENT OPINION IN COLLOID & INTERFACE SCIENCE

Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery

(2008) Marc Muchow et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Nanoparticles for drug delivery: The need for precision in reporting particle size parameters

(2007) Marie Gaumet et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS